Velasco V - Search Results

1

Differential immunohistochemical and biological profile of squamous cell carcinoma of the breast.

Grenier J, Soria JC, Mathieu MC, Andre F, Abdelmoula S, Velasco V, Morat L, Besse B, Dunant A, Spielmann M, Delaloge S. Grenier J, et al. Among authors: velasco v. Anticancer Res. 2007 Jan-Feb;27(1B):547-55. Anticancer Res. 2007. PMID: 17348440 Free article.

2

Immunohistochemical analysis of EGFR and HER-2 in patients with metastatic squamous cell carcinoma of the skin.

Maubec E, Duvillard P, Velasco V, Crickx B, Avril MF. Maubec E, et al. Among authors: velasco v. Anticancer Res. 2005 Mar-Apr;25(2B):1205-10. Anticancer Res. 2005. PMID: 15865067 Free article.

3

Mature tertiary lymphoid structures predict immune checkpoint inhibitor efficacy in solid tumors independently of PD-L1 expression.

Vanhersecke L, Brunet M, Guégan JP, Rey C, Bougouin A, Cousin S, Moulec SL, Besse B, Loriot Y, Larroquette M, Soubeyran I, Toulmonde M, Roubaud G, Pernot S, Cabart M, Chomy F, Lefevre C, Bourcier K, Kind M, Giglioli I, Sautès-Fridman C, Velasco V, Courgeon F, Oflazoglu E, Savina A, Marabelle A, Soria JC, Bellera C, Sofeu C, Bessede A, Fridman WH, Loarer FL, Italiano A. Vanhersecke L, et al. Among authors: velasco v. Nat Cancer. 2021 Aug;2(8):794-802. doi: 10.1038/s43018-021-00232-6. Epub 2021 Aug 12. Nat Cancer. 2021. PMID: 35118423 Free PMC article.

4

Do medulloblastoma tumors meet the Food and Drug Administration criteria for anti-erbB2 therapy with trastuzumab?

Entz-Werle N, Velasco V, Neuville A, Geoerger B, Mathieu MC, Guerin E, Kehrli P, Gaub MP, Vassal G, Grill J. Entz-Werle N, et al. Among authors: velasco v. Pediatr Blood Cancer. 2008 Jan;50(1):163-6. doi: 10.1002/pbc.20908. Pediatr Blood Cancer. 2008. PMID: 16724315

5

Role of bax mutations in apoptosis in colorectal cancers with microsatellite instability.

Miquel C, Borrini F, Grandjouan S, Aupérin A, Viguier J, Velasco V, Duvillard P, Praz F, Sabourin JC. Miquel C, et al. Among authors: velasco v. Am J Clin Pathol. 2005 Apr;123(4):562-70. doi: 10.1309/JQ2X-3RV3-L8F9-TGYW. Am J Clin Pathol. 2005. PMID: 15743744

6

[Adenoid cystic carcinoma of the breast: clinical, histological and immunohistochemical characterization].

Defaud-Hénon F, Tunon-de-Lara C, Fournier M, Marty M, Velasco V, de Mascarel I, MacGrogan G. Defaud-Hénon F, et al. Among authors: velasco v. Ann Pathol. 2010 Feb;30(1):7-16. doi: 10.1016/j.annpat.2010.01.003. Epub 2010 Feb 18. Ann Pathol. 2010. PMID: 20223349 Review. French.

7

Solid-type adenoid cystic carcinoma of the breast, a distinct molecular entity enriched in NOTCH and CREBBP mutations.

Massé J, Truntzer C, Boidot R, Khalifa E, Pérot G, Velasco V, Mayeur L, Billerey-Larmonier C, Blanchard L, Charitansky H, Soubeyran I, Iggo R, Arnould L, MacGrogan G. Massé J, et al. Among authors: velasco v. Mod Pathol. 2020 Jun;33(6):1041-1055. doi: 10.1038/s41379-019-0425-3. Epub 2019 Dec 19. Mod Pathol. 2020. PMID: 31857685 Free article.

8

[Immunohistochemical analysis of EGFR and HER-2 in patients with metastasizing melanoma, Merkel carcinoma and squamous cell carcinoma of the skin].

Maubec E, Duvillard P, Velasco V, Crickx B, Avril MF. Maubec E, et al. Among authors: velasco v. Ann Dermatol Venereol. 2006 Mar;133(3):274-6. doi: 10.1016/s0151-9638(06)77555-x. Ann Dermatol Venereol. 2006. PMID: 16800183 French. No abstract available.

9

Expression of Gastrin-Releasing Peptide Receptor in Breast Cancer and Its Association with Pathologic, Biologic, and Clinical Parameters: A Study of 1,432 Primary Tumors.

Morgat C, MacGrogan G, Brouste V, Vélasco V, Sévenet N, Bonnefoi H, Fernandez P, Debled M, Hindié E. Morgat C, et al. Among authors: velasco v. J Nucl Med. 2017 Sep;58(9):1401-1407. doi: 10.2967/jnumed.116.188011. Epub 2017 Mar 9. J Nucl Med. 2017. PMID: 28280221 Free article.

10

Breast hamartoma: reassessment of an under-recognised breast lesion.

Alran L, Chamming's F, Auriol-Leizagoyen S, Velasco V, Deleau F, Brouste V, Bonhomme B, Ben Rejeb H, Marty M, MacGrogan G. Alran L, et al. Among authors: velasco v. Histopathology. 2022 Jan;80(2):304-313. doi: 10.1111/his.14544. Epub 2021 Sep 22. Histopathology. 2022. PMID: 34403159

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

219 results

Search Page